Ciprofloxacin in the treatment of pneumonia
Open Access
- 1 June 1986
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 29 (6) , 1088-1089
- https://doi.org/10.1128/aac.29.6.1088
Abstract
The use of ciprofloxacin as the sole agent in the treatment of 25 patients with pneumonias caused by susceptible organisms resulted in rapid cure. No side effects, superinfections, or recurrences were observed.This publication has 4 references indexed in Scilit:
- Ciprofloxacin penetration into extravascular spaces in a rabbit modelAntimicrobial Agents and Chemotherapy, 1984
- Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteersAntimicrobial Agents and Chemotherapy, 1984
- In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agentAntimicrobial Agents and Chemotherapy, 1984
- In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1983